Key result
Ultrasound-guided, fluoroscopically controlled implantation of TIVAPs achieved a 99.5% success rate with peri-interventional, early, and late complication rates of 1.4%, 2.9%, and 8.3%.
Why the study?
The study was conducted to retrospectively evaluate success rates, peri-interventional, early, and late complications, and patient satisfaction associated with power-injectable totally implantable venous access devices.
Does ultrasound-guided implantation of power-injectable totally implantable venous access devices result in high success rates and low complications in patients requiring venous access?
Cohort (n=1,169)
Does ultrasound-guided implantation of power-injectable totally implantable venous access devices result in high success rates and low complications in patients requiring venous access?
Ultrasound-guided, fluoroscopically controlled implantation of TIVAPs is a safe procedure with high success rates, low complication rates, and high patient satisfaction.
Answers are grounded in this paper and cite their sources.
Supports ultrasound-guided TIVAP implantation as low-risk with high satisfaction; leaves open randomized confirmation before broader adoption.
Summary. Background: To retrospectively evaluate the success rates, peri-interventional, early and late complications and patient satisfaction associated with power-injectable totally implantable venous access devices (TIVAPs). Patients and methods: Between April 2011 and March 2016, a total of 1,203 TIVAPs were implanted in 1,169 patients. Ultrasound-guided, fluoroscopically controlled implantation was performed through the subclavian or internal jugular vein. The systematic analysis focused on the rate of successful port implantations, the frequency of peri-interventional, early and late complications and on how the experience of the implanting radiologist impacts these parameters. Additionally, a standardized questionnaire was administered to the 102 study patients in a telephone interview to survey their subjective rating of the port implantation. Results: 99.5 % of TIVAPs were implanted successfully. In 4 out of 6 patients, the implantation was repeated successfully at a later time. Complication rates were 1.4 % (0.0512/1.000 catheter days) for peri-interventional, 2.9 % (0.081 per 1,000 catheter days) for early and 8.3 % (0.2288 per 1,000 catheter days) for late complications. The radiologist’s experience level and vein selection did not have a significant impact. Most peri-interventional complications (82.4 %) were of minor severity. The early (61.5 %) and late (65.6 %) complications were more frequently of major severity. Interventions to manage complications comprised port explanation in 46.9 %, conservative therapy in 17.4 % and interventional therapy in 12.2 %. At 1 and 3 months after port placement, the majority were satisfied or very satisfied with the interventional port implantation. Conclusions: Ultrasound-guided, fluoroscopically controlled implantation of TIVAPs is a safe procedure with low complication rates, high success rates and high patient satisfaction.
No takes yet. Share an insight, caveat, or question.
Kunz-Virk et al. (2019) conducted a cohort in Patients requiring venous access devices (n=1,169). Ultrasound-guided, fluoroscopically controlled implantation of TIVAPs was evaluated on successful port implantations. Ultrasound-guided, fluoroscopically controlled implantation of TIVAPs achieved a 99.5% success rate with peri-interventional, early, and late complication rates of 1.4%, 2.9%, and 8.3%.
Synapse has enriched 10 related papers. Consider them for comparative context: